Cargando…

An update on treatment options for primary sclerosing cholangitis

Primary sclerosing cholangitis is a chronic cholestatic liver disease defined by strictures of the biliary tree which could ultimately lead to liver cirrhosis and cholangiocarcinoma. Although the exact underlying etiology of this disorder is not fully understood, the pathology is believed to be caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Iravani, Shahrokh, Dooghaie-Moghadam, Arash, Razavi-Khorasani, Niloofar, Moazzami, Bobak, Dowlati Beirami, Amirreza, Mansour-Ghanaei, Alireza, Majidzadeh-A, Keivan, Mehrvar, Azim, Khoshdel, Alireza, Nasiri Toosi, Mohssen, Sadeghi, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149806/
https://www.ncbi.nlm.nih.gov/pubmed/32308932
_version_ 1783520887643832320
author Iravani, Shahrokh
Dooghaie-Moghadam, Arash
Razavi-Khorasani, Niloofar
Moazzami, Bobak
Dowlati Beirami, Amirreza
Mansour-Ghanaei, Alireza
Majidzadeh-A, Keivan
Mehrvar, Azim
Khoshdel, Alireza
Nasiri Toosi, Mohssen
Sadeghi, Amir
author_facet Iravani, Shahrokh
Dooghaie-Moghadam, Arash
Razavi-Khorasani, Niloofar
Moazzami, Bobak
Dowlati Beirami, Amirreza
Mansour-Ghanaei, Alireza
Majidzadeh-A, Keivan
Mehrvar, Azim
Khoshdel, Alireza
Nasiri Toosi, Mohssen
Sadeghi, Amir
author_sort Iravani, Shahrokh
collection PubMed
description Primary sclerosing cholangitis is a chronic cholestatic liver disease defined by strictures of the biliary tree which could ultimately lead to liver cirrhosis and cholangiocarcinoma. Although the exact underlying etiology of this disorder is not fully understood, the pathology is believed to be caused by immune mediated mechanisms. Growing body of evidence suggests several treatment modalities mainly focusing on the inflammation aspect of this disorder. However, there is still no consensus regarding the best treatment option for these patients. Thus, the present study aimed to review the current treatment options for patients with primary sclerosing cholangitis.
format Online
Article
Text
id pubmed-7149806
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-71498062020-04-17 An update on treatment options for primary sclerosing cholangitis Iravani, Shahrokh Dooghaie-Moghadam, Arash Razavi-Khorasani, Niloofar Moazzami, Bobak Dowlati Beirami, Amirreza Mansour-Ghanaei, Alireza Majidzadeh-A, Keivan Mehrvar, Azim Khoshdel, Alireza Nasiri Toosi, Mohssen Sadeghi, Amir Gastroenterol Hepatol Bed Bench Review Article Primary sclerosing cholangitis is a chronic cholestatic liver disease defined by strictures of the biliary tree which could ultimately lead to liver cirrhosis and cholangiocarcinoma. Although the exact underlying etiology of this disorder is not fully understood, the pathology is believed to be caused by immune mediated mechanisms. Growing body of evidence suggests several treatment modalities mainly focusing on the inflammation aspect of this disorder. However, there is still no consensus regarding the best treatment option for these patients. Thus, the present study aimed to review the current treatment options for patients with primary sclerosing cholangitis. Shaheed Beheshti University of Medical Sciences 2020 /pmc/articles/PMC7149806/ /pubmed/32308932 Text en ©2020 RIGLD, Research Institute for Gastroenterology and Liver Diseases This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Iravani, Shahrokh
Dooghaie-Moghadam, Arash
Razavi-Khorasani, Niloofar
Moazzami, Bobak
Dowlati Beirami, Amirreza
Mansour-Ghanaei, Alireza
Majidzadeh-A, Keivan
Mehrvar, Azim
Khoshdel, Alireza
Nasiri Toosi, Mohssen
Sadeghi, Amir
An update on treatment options for primary sclerosing cholangitis
title An update on treatment options for primary sclerosing cholangitis
title_full An update on treatment options for primary sclerosing cholangitis
title_fullStr An update on treatment options for primary sclerosing cholangitis
title_full_unstemmed An update on treatment options for primary sclerosing cholangitis
title_short An update on treatment options for primary sclerosing cholangitis
title_sort update on treatment options for primary sclerosing cholangitis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149806/
https://www.ncbi.nlm.nih.gov/pubmed/32308932
work_keys_str_mv AT iravanishahrokh anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT dooghaiemoghadamarash anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT razavikhorasaniniloofar anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT moazzamibobak anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT dowlatibeiramiamirreza anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT mansourghanaeialireza anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT majidzadehakeivan anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT mehrvarazim anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT khoshdelalireza anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT nasiritoosimohssen anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT sadeghiamir anupdateontreatmentoptionsforprimarysclerosingcholangitis
AT iravanishahrokh updateontreatmentoptionsforprimarysclerosingcholangitis
AT dooghaiemoghadamarash updateontreatmentoptionsforprimarysclerosingcholangitis
AT razavikhorasaniniloofar updateontreatmentoptionsforprimarysclerosingcholangitis
AT moazzamibobak updateontreatmentoptionsforprimarysclerosingcholangitis
AT dowlatibeiramiamirreza updateontreatmentoptionsforprimarysclerosingcholangitis
AT mansourghanaeialireza updateontreatmentoptionsforprimarysclerosingcholangitis
AT majidzadehakeivan updateontreatmentoptionsforprimarysclerosingcholangitis
AT mehrvarazim updateontreatmentoptionsforprimarysclerosingcholangitis
AT khoshdelalireza updateontreatmentoptionsforprimarysclerosingcholangitis
AT nasiritoosimohssen updateontreatmentoptionsforprimarysclerosingcholangitis
AT sadeghiamir updateontreatmentoptionsforprimarysclerosingcholangitis